Payment of 10936 shares by James Ryan of Gray Television subject to Rule 16b-3
| 22UA Stock | EUR 110.40 5.70 4.91% |
Roughly 62% of BioNTech's investor base is looking to short. The analysis of current outlook of investing in BioNTech SE suggests that many traders are alarmed regarding BioNTech's prospects. The current market sentiment, together with BioNTech's historical and current headlines, can help investors time the market. In addition, many technical investors use BioNTech SE stock news signals to limit their universe of possible portfolio assets.
BioNTech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BioNTech daily returns and investor perception about the current price of BioNTech SE as well as its diversification or hedging effects on your existing portfolios.
BioNTech |
Filed transaction by Gray Television Inc officer. Payment of exercise price or tax liability by delivering or withholding securities
Read at macroaxis.com
BioNTech Fundamental Analysis
We analyze BioNTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
BioNTech is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
BioNTech SE Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioNTech stock to make a market-neutral strategy. Peer analysis of BioNTech could also be used in its relative valuation, which is a method of valuing BioNTech by comparing valuation metrics with similar companies.
Peers
BioNTech Related Equities
| D7G | Nel ASA | 5.26 | ||||
| 5CV | CureVac NV | 4.96 | ||||
| 0QF | Moderna | 3.87 | ||||
| 27W | Powercell Sweden | 4.64 | ||||
| BY6 | BYD Company | 5.24 |
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |